» Articles » PMID: 6933479

Processing of Human Beta-globin MRNA Precursor to MRNA is Defective in Three Patients with Beta+-thalassemia

Overview
Specialty Science
Date 1980 Jul 1
PMID 6933479
Citations 32
Authors
Affiliations
Soon will be listed here.
Abstract

Nucleated bone marrow cells from normal individuals and from three patients with homozygous beta+-thalassemia were pulse-labeled with tritiated nucleosides. The processing of the newly synthesized globin mRNA precursors was monitored by inhibiting additional transcription with actinomycin D for 30 min. Human beta-globin mRNA is derived from its precursor via a series of reactions that generate processing intermediates. In nonthalassemic cells the precursor is processed efficiently to mature mRNA during the chase. In contrast, in beta+-thalassemic cells the processing of beta-globin RNA is defective. In one patient the beta-globin mRNA precursor turns over during the chase, but some of the intermediate RNAs accumulate and are not processed to mRNA. In two other patients a large fraction of the precursor and intermediate RNAs is not processed to mRNA. The alpha-globin mRNA precursor and intermediates are processed efficiently to mRNA-sized molecules in thalassemic and normal cells. The reduction in the rate of beta-globin but not alpha-globin RNA processing accounts for the alpha/beta globin mRNA imbalance in thalassemic erythroid cells. We discuss the possibility that the genetic lesions in beta+-thalassemia are at splicing signal sites within intervening sequences of the beta-globin gene.

Citing Articles

Nonsense-Mediated RNA Decay Is a Unique Vulnerability of Cancer Cells Harboring or Mutations.

Cheruiyot A, Li S, Nonavinkere Srivatsan S, Ahmed T, Chen Y, Lemacon D Cancer Res. 2021; 81(17):4499-4513.

PMID: 34215620 PMC: 8416940. DOI: 10.1158/0008-5472.CAN-20-4016.


The Role of - and -Acting RNA Regulatory Elements in Leukemia.

Elcheva I, Spiegelman V Cancers (Basel). 2021; 12(12).

PMID: 33419342 PMC: 7766907. DOI: 10.3390/cancers12123854.


Blood Relatives: Splicing Mechanisms underlying Erythropoiesis in Health and Disease.

Reimer K, Neugebauer K F1000Res. 2018; 7.

PMID: 30228869 PMC: 6117862. DOI: 10.12688/f1000research.15442.1.


RNA mis-splicing in disease.

Scotti M, Swanson M Nat Rev Genet. 2015; 17(1):19-32.

PMID: 26593421 PMC: 5993438. DOI: 10.1038/nrg.2015.3.


β-thalassemias: paradigmatic diseases for scientific discoveries and development of innovative therapies.

Rivella S Haematologica. 2015; 100(4):418-30.

PMID: 25828088 PMC: 4380714. DOI: 10.3324/haematol.2014.114827.


References
1.
Heller P, YAKULIS V, ROSENZWEIG A, Abildgaard C, RUCKNAGEL D . Mild homozygous beta-thalassemia. Further evidence for the heterogeneity of beta-thalassemia genes. Ann Intern Med. 1966; 64(1):52-61. DOI: 10.7326/0003-4819-64-1-52. View

2.
Hutchison H, Hartwell L, McLaughlin C . Temperature-sensitive yeast mutant defective in ribonucleic acid production. J Bacteriol. 1969; 99(3):807-14. PMC: 250098. DOI: 10.1128/jb.99.3.807-814.1969. View

3.
Nienhuis A, Anderson W . Isolation and translation of hemoglobin messenger RNA from thalassemia, sickle cell anemia, and normal human reticulocytes. J Clin Invest. 1971; 50(11):2458-60. PMC: 292189. DOI: 10.1172/JCI106745. View

4.
Benz Jr E, Forget B . Defect in messenger RNA for human hemoglobin synthesis in beta thalassemia. J Clin Invest. 1971; 50(12):2755-60. PMC: 292227. DOI: 10.1172/JCI106778. View

5.
RIEDER R . Translation of -globin m-RNA in -thalassemia and the S and C hemoglobinopathies. J Clin Invest. 1972; 51(2):364-72. PMC: 302135. DOI: 10.1172/JCI106822. View